These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 29871609)
1. Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report. Zakrzewska-Koperska J; Franaszczyk M; Bilińska Z; Truszkowska G; Karczmarz M; Szumowski Ł; Zieliński T; Płoski R; Bilińska M BMC Med Genet; 2018 Jun; 19(1):94. PubMed ID: 29871609 [TBL] [Abstract][Full Text] [Related]
3. R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. Mann SA; Castro ML; Ohanian M; Guo G; Zodgekar P; Sheu A; Stockhammer K; Thompson T; Playford D; Subbiah R; Kuchar D; Aggarwal A; Vandenberg JI; Fatkin D J Am Coll Cardiol; 2012 Oct; 60(16):1566-73. PubMed ID: 22999724 [TBL] [Abstract][Full Text] [Related]
4. A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation. Zakrzewska-Koperska J; Bilińska ZT; Truszkowska GT; Franaszczyk M; Elikowski W; Warmiński G; Kalin K; Urbanek P; Bodalski R; Orczykowski M; Szumowski Ł; Płoski R; Bilińska M ESC Heart Fail; 2020 Dec; 7(6):4326-4335. PubMed ID: 33084224 [TBL] [Abstract][Full Text] [Related]
5. Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na Calloe K; Broendberg AK; Christensen AH; Pedersen LN; Olesen MS; de Los Angeles Tejada M; Friis S; Thomsen MB; Bundgaard H; Jensen HK Int J Cardiol; 2018 Apr; 257():160-167. PubMed ID: 29506689 [TBL] [Abstract][Full Text] [Related]
6. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. McNair WP; Sinagra G; Taylor MR; Di Lenarda A; Ferguson DA; Salcedo EE; Slavov D; Zhu X; Caldwell JH; Mestroni L; J Am Coll Cardiol; 2011 May; 57(21):2160-8. PubMed ID: 21596231 [TBL] [Abstract][Full Text] [Related]
16. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. Olson TM; Michels VV; Ballew JD; Reyna SP; Karst ML; Herron KJ; Horton SC; Rodeheffer RJ; Anderson JL JAMA; 2005 Jan; 293(4):447-54. PubMed ID: 15671429 [TBL] [Abstract][Full Text] [Related]
17. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Cheng J; Morales A; Siegfried JD; Li D; Norton N; Song J; Gonzalez-Quintana J; Makielski JC; Hershberger RE Clin Transl Sci; 2010 Dec; 3(6):287-94. PubMed ID: 21167004 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Efficacy and Safety of Sodium Channel Antagonists in Patients With p.R222Q SCN5A-Related Arrhythmic Dilated Cardiomyopathy. Peters S; Johnson R; Zentner D; James P; Kalman JM; Fatkin D JACC Clin Electrophysiol; 2021 Jan; 7(1):126-128. PubMed ID: 33478705 [No Abstract] [Full Text] [Related]
19. A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy. Mazzaccara C; Limongelli G; Petretta M; Vastarella R; Pacileo G; Bonaduce D; Salvatore F; Frisso G J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):344-350. PubMed ID: 29782370 [TBL] [Abstract][Full Text] [Related]
20. Bundle Branch Re-Entrant Ventricular Tachycardia: Novel Genetic Mechanisms in a Life-Threatening Arrhythmia. Roberts JD; Gollob MH; Young C; Connors SP; Gray C; Wilton SB; Green MS; Zhu DW; Hodgkinson KA; Poon A; Li Q; Orr N; Tang AS; Klein GJ; Wojciak J; Campagna J; Olgin JE; Badhwar N; Vedantham V; Marcus GM; Kwok PY; Deo RC; Scheinman MM JACC Clin Electrophysiol; 2017 Mar; 3(3):276-288. PubMed ID: 29759522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]